Protamine sulfate 1%,10 mg/ml, solution for injection
Protamini sulfas
Protamine sulfate 1% contains the active substance protamine sulfate. Protamine is a mixture of
low molecular weight, strongly basic peptides rich in arginine.
Protamine forms complexes with heparin, thereby neutralizing its anticoagulant effect.
Protamine sulfate 1% is used to counteract the anticoagulant effect of heparin.
After intravenous administration of the appropriate dose of protamine sulfate, neutralization of heparin's anticoagulant effect occurs within 5 minutes.
Do not use in patients who have:
This medicine should not be used in patients with diabetes who have received or are receiving protamine-containing insulin products, due to the risk of acute adverse reactions, including anaphylactic reactions (severe allergic reactions).
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Protamine sulfate 1% is incompatible with some antibiotics, mainly penicillin and cephalosporin derivatives, amidotrizoic acid and ioxaglate and their derivatives used in diagnostics.
There are insufficient data on the use of Protamine sulfate 1% in pregnant and breastfeeding women.
The doctor should exercise caution when prescribing Protamine sulfate 1% to pregnant and breastfeeding women.
This does not apply, as patients receiving Protamine sulfate 1% are hospitalized after cardiovascular surgery.
The use of the medicine is decided by the doctor.
The medicine is for use in a hospital setting.
Route of administration:intravenous.
Protamine sulfate 1% administered by a route other than intravenous does not neutralize heparin.
Neutralization of heparin's anticoagulant effect should be carried out under close medical and laboratory control, especially the partial thromboplastin time (APTT) or coagulation time (ACT), in order to achieve a normal, physiological level of blood coagulation, i.e. blood clotting.
In case of doubt, consult your doctor again.
The dose of protamine sulfate depends on the time elapsed since intravenous administration of heparin and its amount.
It is assumed that 1 mg of protamine sulfate neutralizes the anticoagulant effect of approximately 100 IU of heparin. This neutralization usually occurs within 5 minutes after intravenous injection of protamine sulfate. Regardless of the route of heparin administration (intravenous, subcutaneous, intradermal), 5 ml (1 ampoule) of Protamine sulfate 1% is administered intravenously. If necessary, this procedure can be repeated once or several times at 10-15 minute intervals. Excessive excess of protamine sulfate may enhance anticoagulant effect.
After 3 hours of subcutaneous or intramuscular administration of heparin, when its prolonged anticoagulant effect occurs, the administration of protamine should be repeated.
Do not exceed the rate of administration of the medicine:
10 mg/ml should be administered no faster than 3 minutes,
50 mg/5 ml should be administered no faster than 10 minutes.
The medicine should be administered slowly: too rapid injection intensifies adverse reactions. It is recommended to administer the average dose of 50 mg over 10 minutes (no faster).
Intervals between subsequent doses of 50 mg of protamine sulfate in 5 ml should be from 10 to 15 minutes.
Additional doses should be calculated and administered based on the result of the patient's blood coagulation tests (APTT, ACT), which are recommended to be performed within 5 to 15 minutes after administration of Protamine sulfate 1%.
In case of use of a higher than recommended dose of the medicine, immediately consult a doctor or pharmacist.
Do not use a double dose to make up for a missed dose.
In case of any further doubts regarding the use of this medicine, consult a doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
After administration of Protamine sulfate 1%, short-term and moderate side effects may occur, usually from the cardiovascular system:
Very rare: (occurring in less than 1 in 10,000)
may occur transiently: | |
leukopenia and thrombocytopenia (decreased white blood cell and platelet count), feeling of fatigue, | |
back pain, nausea, vomiting, shortness of breath, wheezing, bronchospasm, urticaria, skin flushing | |
of the skin. | |
In patients allergic to protamine or fish, in patients with antibodies against protamine, and in diabetic patients who received protamine insulin, acute adverse reactions may occur, including anaphylactic shock. | |
These reactions occur after injection of 15 mg to 35 mg of Protamine sulfate 1%. In these patients, skin tests for hypersensitivity to protamine sulfate should be performed before the procedure. | |
In case of allergy to protamine, the doctor will consider using another method of neutralizing heparin's effect or administering another substance that neutralizes heparin's effect. | |
In cases of allergic reactions, the use of adrenaline and corticosteroids gives good results. | |
Within 30 minutes to 18 hours after heart surgery, a heparin/protamine complex dissociation reaction may occur, resulting in hyperheparinemia or bleeding. | |
In order to prevent the release of heparin, an additional dose of protamine sulfate should be administered, the size of which is determined based on the laboratory test of the patient's blood coagulation. | |
Protamine sulfate, the size of which is determined based on the laboratory test of the patient's blood coagulation.
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
{current address, phone and fax number of the above Department}
e-mail: adr@urpl.gov.pl .
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C. Do not store in the refrigerator or freeze.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The medicine is a solution for injection.
5 ml glass ampoules containing the solution for injection, in a cardboard box.
The pack contains 1 or 10 ampoules.
Not all pack sizes may be marketed.
BIOMED Serum and Vaccine Plant Ltd.
Chełmska 30/34 Street
00-725 Warsaw
phone: 22 841 40 71
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.